Search

Search Constraints

You searched for: Author/Creator Hicking, Christine

Search Results

1. 039 Rates of lymphopenia in years 1–4 in patients with relapsing multiple sclerosis treated annually with cladribine tablets. Issue 6 (24th May 2018)

2. 040 An analysis of malignancy risk in the clinical development programme of cladribine tablets in patients with relapsing multiple sclerosis. Issue 6 (24th May 2018)

3. Cladribine tablets added to IFN-β in active relapsing MS: The ONWARD study. Issue 5 (September 2018)

4. Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study. (May 2019)

6. PO136 Durable efficacy of cladribine tablets: clarity+extension. (1st December 2017)

10. Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets. (February 2018)